Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Efficacy Study of Bimatoprost in the Treatment of Men With Androgenic Alopecia

NCT01325337 is registered in ClinicalTrials.gov with Allergan as lead sponsor.

NCT NCT01325337
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01325337 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Efficacy Study of Bimatoprost in the Treatment of Men With Androgenic Alopecia
Lead sponsor
Allergan
Phase
Phase 2
Overall status
Completed
Start date
June 30, 2011
Completion date
September 30, 2012
Enrollment
307 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

alopecia, alopecia, androgenetic, baldness